Government Asks Permission to Keep Doing Its Job
Published Date: 11/26/2025
Notice
Summary
The National Library of Medicine wants your thoughts on keeping and improving a big list of clinical trials and their results. This helps doctors, patients, and researchers find trustworthy info faster. If you’re involved in clinical trials or just curious, you can comment within 60 days—no extra costs, just your ideas to make things better!
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Mandatory Trial Registration and Results Reporting
The rule requires registration of certain applicable clinical trials and submission of results under 42 CFR part 11 for drug, biological, and device trials, whether or not products are FDA-approved. NIH estimates a total annualized respondent burden of 1,411,181 hours and requests OMB approval for 3 years with an expiration date of 03/31/2026.
Continued Public Access to ClinicalTrials.gov Information
NIH will continue operating ClinicalTrials.gov to collect trial registrations and results so patients, physicians, and researchers can find trustworthy clinical study information and track study progress to benefit public health. The notice seeks public comment for 60 days and states there are no monetary costs to respondents other than their time.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11892 — Proposed Collection; 60-Day Comment Request; Specimen Resource Locator (National Cancer Institute)
The National Cancer Institute wants your thoughts on a new way to track and locate cancer research samples through their Specimen Resource Locator. This affects researchers and labs who use these samples, aiming to make finding and sharing easier without adding extra costs or delays. You’ve got 60 days to share your feedback and help shape this helpful tool!
2026-11390 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding to advance science. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-11357 — National Library of Medicine; Notice of Partially Closed Meeting
The National Library of Medicine’s Board of Regents will hold a virtual meeting on July 16, 2026, with some parts open to the public and others closed to protect private info and trade secrets. This meeting affects researchers and grant applicants, as grant reviews will happen behind closed doors. Anyone can watch the open sessions online and send comments up to 15 days before the meeting—no registration needed!
2026-11367 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for exciting science projects. If you’re involved in cell biology, heart disease, mental health, or cancer research, these reviews could impact your funding timeline and opportunities.
2026-11018 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late June and early July 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which scientific projects get funding. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-10813 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health just announced a cool new antibody called 18H2 that helps scientists spot a key protein in immune cells that keep us healthy. This invention is ready for companies to license and turn into real products, speeding up research and treatments for autoimmune diseases. If you’re interested, now’s the time to reach out and get the details—money and timing depend on your licensing deal!
Previous / Next Documents
Previous: 2025-21243 — Agency Information Collection Activities: Requests for Comments; Clearance of Renewed Approval of Information Collection: Suspected Unapproved Parts Report
The FAA is renewing its approval to collect reports about suspected unapproved aircraft parts from manufacturers, repair shops, airlines, and the public. This helps keep our skies safe by spotting risky parts early. If you have thoughts on this process, you’ve got until December 26, 2025, to share them—no cost to report, just your time!
Next: 2025-21245 — Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company
Some folks want to buy or keep shares in banks or bank companies, and the Federal Reserve is checking their applications to make sure everything’s fair and safe. If you want to share your thoughts, you’ve got until December 11, 2025, to speak up! This process helps keep banks strong and protects everyone’s money.